tiprankstipranks
Helix BioPharma (TSE:HBP)
TSX:HBP
Canadian Market

Helix BioPharma (HBP) Income Statement

Compare
25 Followers

Helix BioPharma Income Statement

Last quarter (Q1 2025), Helix BioPharma's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Helix BioPharma's net income was C$-1.34M. See Helix BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -14.00KC$ -13.00KC$ -12.00KC$ -173.00KC$ -212.00K
Operating Expenses
C$ 9.36MC$ 6.33MC$ 6.04MC$ 9.13MC$ 8.62M
Depreciation and Amortization
C$ 14.00KC$ 13.00KC$ 12.00KC$ 173.00KC$ 212.00K
EBITDA
C$ -9.38MC$ -6.31MC$ -6.03MC$ -9.46MC$ -8.44M
Operating Income
C$ -9.37MC$ -6.28MC$ -6.54MC$ -9.61MC$ -8.59M
Other Income/Expenses
C$ -25.00KC$ 36.00KC$ -523.00KC$ -443.00KC$ 55.00K
Pretax Income
C$ -9.40MC$ -6.29MC$ -6.56MC$ -9.57MC$ -8.56M
Net Income
C$ -9.26MC$ -6.29MC$ -6.08MC$ -7.91MC$ -9.01M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.21C$ -0.16C$ -0.20C$ -0.29C$ -0.35
Diluted EPS
C$ -0.21C$ -0.16C$ -0.20C$ -0.29C$ -0.35
Weighted Average Shares Outstanding
44.49M 38.65M 29.90M 27.58M 25.54M
Weighted Average Shares Outstanding (Diluted)
44.49M 38.65M 29.90M 27.58M 25.54M
Currency in CAD

Helix BioPharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis